Molecular Partners AG

MOLNNASDAQHealthcare● Active

$3.95

$-0.15(-3.66%)

Market Cap$148168932

P/E Ratio—

52W High$5.36

52W Low$3.41

Avg Volume4K

Open$3.90

Beta0.71

Overview

Molecular Partners AG (MOLN) Net Income & Profit History

Annual & trailing net income, net margin, YoY change, and peer profitability context.

MOLN · net income · updated Jun 9, 2026

Core profitability metrics

MOLN · net income · margin · TTM · CAGR

Net income was −$61.7M for FY2025 (fiscal year ending 2025-12-31), down 14.1% year-over-year. Net profit margin was —. Based on available data, Molecular Partners AG has been profitable since at least 2013.

FY2025 Net Income−$61.7M▼ -14.1% YoY

Trailing 12M (TTM)−$72.1Mtrailing 4 quarters sum

Net Profit Margin——

YoY Change-14.1%—

5-Year CAGRN/AN/A — contains loss years

FormulaNet Margin = Net Income ÷ Revenue × 100TTM = trailing 4 quarters sumCAGR → N/A if either endpoint ≤ 0

Source: FMP /income-statement · US GAAP · USDUpdated: Jun 9, 2026

Annual net income history

Net Income (bars) · Net Profit Margin % (line)

Net IncomeNet LossNet Margin %★ First Profit: 2013

▸ FMP /income-statement · Annual · MOLN net income history · MOLN profit margin

Annual net income data

MOLN · net income history · annual / quarterly

Fiscal YearNet IncomeYoY ChangeNet MarginRevenue

FY2025Loss−$61.7M▼ 14.1%—$0

FY2024Loss−$54.0M▲ +12.8%-1087.4%$5.0M

FY2023Loss−$62.0M▼ 152.6%-880.7%$7.0M

FY2022$117.9M▲ +284.8%62.2%$189.6M

FY2021Loss−$63.8M▼ 1.6%-683.6%$9.3M

Net income vs peers (Healthcare)

MOLN vs peers · net income

#CompanyNet IncomeYoYNet MarginRelative

Molecular Partners AGYOU

MOLN

−$61.7M-14.1%—

Loss

Eli Lilly and Company

LLY

$20.64B+94.9%31.7%

77%

UnitedHealth Group Incorporated

Healthcare · Sorted by Net Income · FMP /income-statementFull Net Income Rankings →

About Net Income & Methodology

Molecular Partners AG (MOLN) reported net income of −$61.7M for FY2025 (fiscal year ending 2025-12-31), down 14.1% year-over-year. The net profit margin was — — meaning the company kept $— of every dollar of revenue as profit.

Based on available data, Molecular Partners AG has been profitable since at least 2013. Net income reached a peak of $117.9M in FY2022. Data available for 13 fiscal years.

Molecular Partners AG's net profit margin was — for FY2025, based on the latest annual results.

Investors sometimes search for "Molecular Partners AG net worth" — the company's market capitalization is a separate figure from MOLN net income. Data sourced from FMP /income-statement · US GAAP · USD.

Figures tie to SEC 10-K/10-Q and FMP /income-statement where noted.

Revenue Financial statements Earnings Forecast Price history Market cap Free cash flow

Frequently asked questions

MOLN net income · 4 questions

Molecular Partners AG is not currently profitable on an annual basis. The company reported a net loss of $61.7M for FY2025.

is MOLN profitabledoes MOLN make a profitMOLN profitabilityMOLN profitable company

▸ Source: FMP /income-statement · GAAP · Molecular Partners AG · Molecular Partners AG SEC 10-K & 10-Q filings · US GAAP · Last updated: Jun 9, 2026